Can't agree more. I see Cirtran came up with yet another SEC filling for yet another $1.5MM, this time with Cornell (rather than its Bermuda arm, as in Dec. 20's). Otherwise, the same conditions apply. Cornell can convert at the lowest PPS (over a period of 20 days). This is how they make the money. They (somehow) force the price drop to the level they are willing to pay, then they re-sell the shares at a higher price. This is the most perverse way of shorting the stock.
Today news (adding an additional $22MM to the already booked $80MM last year) are good news. But, IMO, this stock will go where it belongs only after they get rid of the poisonous Cornell financing, and significantly reduce the OS. Why in the world can't Citran find an alternate to Cornell financing it's beyond me.
Mike
Recent CIRX News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 09:11:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 07:37:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:12:01 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 06:47:40 PM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM